CIC
RMD icon

Cornercap Investment Counsel’s ResMed RMD Stock Holding History

Cornercap Investment Counsel’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,896
Closed -$1.76M – 680
2024
Q1 		$1.76M Buy
+8,896
New +$1.63M 0.27% 105
2018
Q2 		– Sell
-2,736
Closed -$269K – 443
2018
Q1 		$269K Sell
2,736
-1,855
-40% -$175K 0.04% 378
2017
Q4 		$389K Hold
4,591
– – 0.05% 367
2017
Q3 		$353K Buy
+4,591
New +$351K 0.05% 372

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cornercap Investment Counsel's RMD Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of ResMed (RMD) in Q2 2024, closing a stake of 8,896 shares — an estimated $1.76M sold.

Cornercap Investment Counsel first reported a position in RMD in Q3 2017 and held it in 4 quarters. The position peaked at $1.76M in Q1 2024. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Cornercap Investment Counsel reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 8,896 ResMed shares in Q2 2024, an estimated $1.76M.
  • Cornercap Investment Counsel first reported a position in ResMed in Q3 2017 and held it in 4 quarters.
  • Cornercap Investment Counsel's ResMed position peaked at $1.76M in Q1 2024.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.